PharmaShots | Incisive News in 3 Shots

Subscribe Now

program decision

Revance and Mylan to Extend Biosimilar to BOTOX Program Decision Beyond April 30- 2020

Revance and Mylan to Extend Biosimilar to BOTOX Program Decision Beyond April 30- 2020

May 4, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us